Global Cardiovascular and Soft Tissue Repair Patches Market By Application (Cardiac repair, Vascular repair & reconstruction), By Raw Material, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Cardiovascular and Soft Tissue Repair Patches Market Overview:

The global cardiovascular and soft tissue repair patches market was valued at USD 4,000 million in 2021. It is projected to grow at an 8% CAGR between the forecast period 2023 and 2032.

This market is experiencing rapid growth due to the rising incidence of congenital heart disease across the globe. According to data published by the Centers for Disease Control and Prevention on congenital diseases, nearly 1% of all U.S. live births are affected by congenital heart diseases. Ventricular septal defect and atrial septal defect (ASD) are the most common congenital diseases.

Because of the COVID-19 pandemic, To curb the transmission rate, the government imposed multiple lockdowns and travel restrictions. This imposition caused a force to prioritize procedures in healthcare facilities and a sharp decline in elective surgical procedures.

Global Cardiovascular and Soft Tissue Repair Patches Market Scope:

Application analysis

Soft tissue dominated the market for soft tissue repair patches for cardiovascular and soft tissues and was responsible for 40% of the total revenue in 2021. This is due to the rapid increase in hernias such as ventral hernias and umbilical hernias. The segment is experiencing a growing number of inguinal and peritoneal hernia surgeries. Inguinal hernia surgeries were performed in approximately 28% of Americans, according to International Surgery Journal estimates.

The market for cardiac and soft tissue patches is expected to grow at the fastest rate over the next few years. The rising number of congenital heart diseases in the global pediatric population is driving the demand for cardiac patches. According to studies, the prevalence rate for the atrial septal defect in children is 15% and in adults 35% respectively.

Two connected cardiac patches are permanently placed in the hole for the repair of the atrial septal defect. They cover the left and right atrial sides. The patch is sealed after a few months as the lining of your heart wall grows over it. Cardiac reconstruction and vascular reconstruction are segments of cardiovascular repair segments.

Raw Material analysis

ePTFE dominated the soft tissue repair patches and cardiovascular market, accounting for the largest revenue share at 61.4% in 2021. This is due to multiple benefits of ePTFE, such as its high tensile strength and durability, and ease of use.

ePTFE is also used in medical accessories like wound care materials and transducer protectors. The biomaterial and tissue-engineered material segment will experience the fastest growth in the market for soft tissue repair patches and cardiovascular products over the next few years.

Bovine pericardium is becoming a popular raw material for making soft tissue and cardiovascular repair patches. Bovine pericardium has many physical and chemical advantages that are driving its adoption.

Bovine pericardium’s advantages, such as its ease of acceptance in the human body and reduced risk of complications after surgery, are driving this growth. The bovine pericardium has a high level of structural protein, which provides enhanced flexibility and conformity to suit multiple anatomical conditions. These patches can be customized to suit any size or configuration. These patches offer enhanced convenience, reliability, and biocompatibility.

Key Market Segments

By Application

• Cardiac repair
• Vascular repair & reconstruction
• Pericardial repair
• Dural repair
• Soft Tissue Repair

By Raw Material

• ePTFE
• Biomaterial and tissue-engineered material
• Other Raw Materials

Market Dynamics:

There is a growing demand for patches to diagnose and treat cardiac and soft tissue conditions. This has prompted collaboration efforts between key manufacturers, raw material suppliers, and research organizations to create innovative products.

Key players are also focusing their efforts on the development of novel technologies made of tissue engineering materials. This will help to increase the growth of the market in soft tissue repair and cardiovascular patches.

A Tel Aviv University research team has created a bionic patch for the heart. This product is made from organic living tissue and a nanoelectronic device. It could be used to support patients recovering from heart attacks. To boost growth and development, the growing demand is driving public-private partnerships in several markets.

Governments are taking steps to make it more affordable and easier to access cardiac treatment options. This is expected to help support growth. The Japanese government supported and recognized the Osaka Medical College’s collaboration with Teijin Limited and Fukui Warp Knitting Co. Ltd., which developed regenerative cardiac repair patches. It is becoming easier for governments to support and encourage collaboration between medical and industrial players.

Obtaining Premarket Approval (PMA) for products is made mandatory by FDA in US, before introducing their product in the market.

Regional Analysis

North America was the dominant market for soft tissue and cardiovascular repair patches in 2021, accounting for 38.2% of the total revenue. This is due to rapidly changing lifestyles and the increasing prevalence of heart disease, hernia disorders, increased alcohol consumption, smoking, obesity, and growing substance abuse. According to the Annals of Laparoscopic Surgery 2019.

The US performs 3,50,000 abdominal wall hernia surgeries are performed annually in the United States. The market for soft tissue and cardiovascular repair patches is being driven by increasing disposable income, improved healthcare infrastructure, the availability of new products and technologies, as well as the presence of key players in North America. The market is also being driven by the increasing collaboration between raw material suppliers, pharmaceutical companies, and government agencies.

The Asia Pacific will experience the fastest growth rate due to rapid advances in healthcare infrastructure, increasing trends in minimally invasive surgery, rising incidences of cardiac disease, and growing medical tourism. There is also a growing geriatric population and a rising prevalence of chronic diseases.

The growth is being driven by a growing awareness of the importance of early diagnosis and treatment for congenital heart disease.

According to World Health Organization estimates, cardiovascular disease incidence is expected to increase by 50% annually between 2023- 2032. This will drive growth opportunities in the Asia Pacific for soft tissue repair patches and cardiovascular products.

Key Regions and Countries covered іn thе rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UNITED KINGDOM
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Competitive Landscape:

To expand their product range and increase their competitive edge, the key players always focus on developing innovative product development strategies. These key players also plan to increase their business footprint through mergers and acquisitions as well as partnership strategies.

Terumo Cardiovascular, for example, launched AQUABRID, a new surgical sealant that can be used during aorta surgery procedures in 2020. In a similar vein, CryoLife and Misonix formed a strategic alliance in which CryoLife’s NeoPatch would be granted special commercialization rights in the U.S. market.

Admedus, Abbott, LeMaitre Vascular Inc., LIFENET HEALTH INC, STRYKER CORPORATION, REGENIX GROUP PLC, Tissue Regenix Group Plc, FOC Medical S.A., Terumo Corporation, Baxter International, Inc., Medprin Regenerative Medical Technologies Co., Ltd., Organogenesis Inc., Terumo Medical Corporation, and others are some prominent players in Global Cardiovascular and Soft Tissue Repair Patches Market. The market for soft tissue and cardiovascular repair patches is dominated by the following:

Маrkеt Kеу Рlауеrѕ:

• Baxter
• Admedus
• Abbott
• Baxter International, Inc.
• LeMaitre Vascular Inc.
• Terumo Medical Corporation
• Edwards Life Sciences Corporation
• Glycar SA Pty Ltd.
• LabCor
• Other Key Players

For the Cardiovascular and Soft Tissue Repair Patches Market research study, the following years have been considered to estimate the market size: